Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

CAR T cell therapy and the tumor microenvironment: Current challenges and opportunities
Lionel Aurelien Kankeu Fonkoua, Olivia Sirpilla, Reona Sakemura, et al.
Molecular Therapy — Oncolytics (2022) Vol. 25, pp. 69-77
Open Access | Times Cited: 148

Showing 1-25 of 148 citing articles:

Lung cancer immunotherapy: progress, pitfalls, and promises
Aritraa Lahiri, Avik Maji, Pravin D. Potdar, et al.
Molecular Cancer (2023) Vol. 22, Iss. 1
Open Access | Times Cited: 526
Exploring treatment options in cancer: Tumor treatment strategies
Beilei Liu, Hongyu Zhou, Licheng Tan, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 175
The current landscape of CAR T-cell therapy for solid tumors: Mechanisms, research progress, challenges, and counterstrategies
Amin Daei Sorkhabi, Leila Mohamed Khosroshahi, Aila Sarkesh, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 102
Modulating extracellular matrix stiffness: a strategic approach to boost cancer immunotherapy
Zizhao Mai, Yunfan Lin, Pei Lin, et al.
Cell Death and Disease (2024) Vol. 15, Iss. 5
Open Access | Times Cited: 79
Advancing CAR T cell therapy through the use of multidimensional omics data
Jingwen Yang, Yamei Chen, Ying Jing, et al.
Nature Reviews Clinical Oncology (2023) Vol. 20, Iss. 4, pp. 211-228
Closed Access | Times Cited: 65
CAR T Cell Therapy: A Versatile Living Drug
Rodrigo C. De Marco, Héctor J. Monzó, Päivi M. Ojala
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 7, pp. 6300-6300
Open Access | Times Cited: 63
Mechanisms of resistance to chimeric antigen receptor-T cells in haematological malignancies
Marco Ruella, Felix Korell, Patrizia Porazzi, et al.
Nature Reviews Drug Discovery (2023) Vol. 22, Iss. 12, pp. 976-995
Open Access | Times Cited: 58
CAR T therapies in multiple myeloma: unleashing the future
Mohsen Sheykhhasan, Amirhossein Ahmadieh-Yazdi, Rosario Vicidomini, et al.
Cancer Gene Therapy (2024) Vol. 31, Iss. 5, pp. 667-686
Open Access | Times Cited: 49
The CAR macrophage cells, a novel generation of chimeric antigen-based approach against solid tumors
Kaveh Hadiloo, Siavash Taremi, Mahmood Heidari, et al.
Biomarker Research (2023) Vol. 11, Iss. 1
Open Access | Times Cited: 45
Anti-CTLA-4 nanobody as a promising approach in cancer immunotherapy
Mehregan Babamohamadi, Nastaran Keshavarz Mohammadi, Elham Faryadi, et al.
Cell Death and Disease (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 32
Vascular remodelling in cardiovascular diseases: hypertension, oxidation, and inflammation
Justyna Totoń‐Żurańska, T. Mikołajczyk, Blessy Saju, et al.
Clinical Science (2024) Vol. 138, Iss. 13, pp. 817-850
Closed Access | Times Cited: 29
Focused ultrasound-assisted delivery of immunomodulating agents in brain cancer
Elahe Memari, Dure Khan, Ryan Alkins, et al.
Journal of Controlled Release (2024) Vol. 367, pp. 283-299
Closed Access | Times Cited: 18
Beyond the blood: expanding CAR T cell therapy to solid tumors
Uğur Uslu, Carl H. June
Nature Biotechnology (2024)
Closed Access | Times Cited: 17
CAR-T cell therapy: developments, challenges and expanded applications from cancer to autoimmunity
Yaxian Kong, Jingyao Li, Xia Zhao, et al.
Frontiers in Immunology (2025) Vol. 15
Open Access | Times Cited: 3
Engineering Induced Pluripotent Stem Cells for Cancer Immunotherapy
Yang Zhou, Miao Li, Kuangyi Zhou, et al.
Cancers (2022) Vol. 14, Iss. 9, pp. 2266-2266
Open Access | Times Cited: 40
Mechanisms of Resistance and Treatment of Relapse after CAR T-cell Therapy for Large B-cell Lymphoma and Multiple Myeloma
Kai Rejeski, Michael D. Jain, Eric L. Smith
Transplantation and Cellular Therapy (2023) Vol. 29, Iss. 7, pp. 418-428
Open Access | Times Cited: 31
IGF2BP family of RNA-binding proteins regulate innate and adaptive immune responses in cancer cells and tumor microenvironment
Irina Elcheva, Chethana P. Gowda, Daniel Bogush, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 28
Genetically Programmable Vesicles for Enhancing CAR‐T Therapy against Solid Tumors
Xianjun Li, Tianchuan Zhu, Ronghao Wang, et al.
Advanced Materials (2023) Vol. 35, Iss. 19
Closed Access | Times Cited: 24
Disruption of TGF-β signaling pathway is required to mediate effective killing of hepatocellular carcinoma by human iPSC-derived NK cells
Jaya Lakshmi Thangaraj, Michael Coffey, Edith Lopez, et al.
Cell stem cell (2024) Vol. 31, Iss. 9, pp. 1327-1343.e5
Closed Access | Times Cited: 16
Breast cancer-on-chip for patient-specific efficacy and safety testing of CAR-T cells
Tengku Ibrahim Maulana, Claudia Teufel, Madalena Cipriano, et al.
Cell stem cell (2024) Vol. 31, Iss. 7, pp. 989-1002.e9
Open Access | Times Cited: 15
Future perspectives on engineered T cells for cancer
Avery D. Posey, Regina M. Young, Carl H. June
Trends in cancer (2024) Vol. 10, Iss. 8, pp. 687-695
Open Access | Times Cited: 14
Chimeric Antigen Receptor T Cell Therapy for Pancreatic Cancer: A Review of Current Evidence
Agata Czaplicka, Mieszko Lachota, Leszek Pączek, et al.
Cells (2024) Vol. 13, Iss. 1, pp. 101-101
Open Access | Times Cited: 13
The next frontier in immunotherapy: potential and challenges of CAR-macrophages
Jing Li, Ping Chen, Wenxue Ma
Experimental Hematology and Oncology (2024) Vol. 13, Iss. 1
Open Access | Times Cited: 12
From Crypts to Cancer: A Holistic Perspective on Colorectal Carcinogenesis and Therapeutic Strategies
Ehsan Gharib, Gilles A. Robichaud
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 17, pp. 9463-9463
Open Access | Times Cited: 9
Harnessing phytochemicals: innovative strategies to enhance cancer immunotherapy
Qianru Zhu, Ruonan Zhang, Min Jin Ha, et al.
Drug Resistance Updates (2025) Vol. 79, pp. 101206-101206
Open Access | Times Cited: 1
Page 1 - Next Page

Scroll to top